Back to search
FDAFDA · Food and drugs·Recall number Z-1522-2021

CareLink SmartSync Device Manager (24970A). used to interrogate cardiac implantable electronic devices (CIED).

Published May 12, 2021 · Recall initiated: April 6, 2021

Summary

FDA records medical device Class II recall Z-1522-2021, published May 12, 2021 and initiated April 6, 2021. Recalling firm: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF); Status: Ongoing; Reported quantity: 16,311 devices; Lot: All serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommended Replacement Time (RRT).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Distributor
Worldwide
Lot
All serial numbers
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CareLink SmartSync Device Manager (24970A). used to interrogate cardiac implantable electronic devices (CIED). recalled?

Yes. FDA published recall Z-1522-2021 on May 12, 2021. Reported hazard: There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommended Replacement Time (RRT).

What should I do if I have this product?

Voluntary: Firm initiated · Letter